Nicholas A. White
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicholas A. White has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Francis Gosselin
Department of Synthetic Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
8 shared publications - Lauren E. Sirois
Department of Synthetic Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
8 shared publications - Haiming Zhang
Department of Synthetic Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
5 shared publications Jeff Shen
Department of Synthetic Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
4 shared publications- Kyle Clagg
Department of Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
4 shared publications - Joseph Michael Dennis
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
3 shared publications
Latest Publications
- 15 September 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (10) , 2743-2754
Synthesis of the Substituted 7-Azaindazole Core of TEAD Inhibitor GDC-8025 via Gould–Jacobs Cyclization and Halogen Dance Routes
Herein we report our efforts to identify a convergent and efficient route to the highly substituted 7-azaindazole core of GDC-8025, a potent pan-TEAD inhibitor. We investigated two orthogonal routes to access the requisite 4-iodo-1-aryl-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile intermediate. The first of these featured a one-flask halogen dance rearrangement/acylation to enable construction of the pyrazole ring around a pyridine starting material. The second route relied on elaboration of a highly substituted aminopyrazole to a Meldrum’s acid derivative, which then engaged in a Gould–Jacobs cyclization to form the pyridine ring. Both routes were found to be effective and efficient means of accessing the target GDC-8025 precursor in 6 steps from economical starting materials.
- 15 September 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (10) , 2743-2754
Synthesis of the Substituted 7-Azaindazole Core of TEAD Inhibitor GDC-8025 via Gould–Jacobs Cyclization and Halogen Dance Routes
Herein we report our efforts to identify a convergent and efficient route to the highly substituted 7-azaindazole core of GDC-8025, a potent pan-TEAD inhibitor. We investigated two orthogonal routes to access the requisite 4-iodo-1-aryl-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile intermediate. The first of these featured a one-flask halogen dance rearrangement/acylation to enable construction of the pyrazole ring around a pyridine starting material. The second route relied on elaboration of a highly substituted aminopyrazole to a Meldrum’s acid derivative, which then engaged in a Gould–Jacobs cyclization to form the pyridine ring. Both routes were found to be effective and efficient means of accessing the target GDC-8025 precursor in 6 steps from economical starting materials.
- 23 October 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (44) , 41130-41137
Hydrogen-Mediated Reductive Cross-Coupling of Aryl Iodides with Activated Aryl and Heteroaryl Bromides
Hydrogen-mediated reductive cross-couplings of aryl iodides with activated aryl and heteroaryl bromides are described, along with related homocouplings (Ullmann reactions) and vinylic reductive couplings that occur with cine-substitution. To corroborate key events in the catalytic cycle, Pd-to-Pd transmetalation and cross-selective reductive elimination, dianionic diarylpalladate complexes [Pd(Aryl)(μ-Br)Br]2[NPr4]2 bearing p-fluorophenyl, p-methoxyphenyl and p-nitrophenyl moieties were prepared. Stoichiometric reactions of these complexes in the presence of iodide demonstrate that Pd-to-Pd transmetalation by way of monomeric arylpalladates occurs at a greater rate than reductive elimination and that cross-selective C-C reductive elimination is favored for electronically distinct aryl partners. Hydrogen-mediated reductive cross-coupling of aryl iodides with α-bromostyrene occurs with cine-substitution (as observed in related formate-mediated processes), consistent with carbopalladation of α-bromostyrene by monomeric arylpalladates Pd(Aryl)I2[NBu4] that arise upon dissociation of [Pd(Aryl)(μ-I)I]2[NBu4]2.
- 23 October 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (44) , 41130-41137
Hydrogen-Mediated Reductive Cross-Coupling of Aryl Iodides with Activated Aryl and Heteroaryl Bromides
Hydrogen-mediated reductive cross-couplings of aryl iodides with activated aryl and heteroaryl bromides are described, along with related homocouplings (Ullmann reactions) and vinylic reductive couplings that occur with cine-substitution. To corroborate key events in the catalytic cycle, Pd-to-Pd transmetalation and cross-selective reductive elimination, dianionic diarylpalladate complexes [Pd(Aryl)(μ-Br)Br]2[NPr4]2 bearing p-fluorophenyl, p-methoxyphenyl and p-nitrophenyl moieties were prepared. Stoichiometric reactions of these complexes in the presence of iodide demonstrate that Pd-to-Pd transmetalation by way of monomeric arylpalladates occurs at a greater rate than reductive elimination and that cross-selective C-C reductive elimination is favored for electronically distinct aryl partners. Hydrogen-mediated reductive cross-coupling of aryl iodides with α-bromostyrene occurs with cine-substitution (as observed in related formate-mediated processes), consistent with carbopalladation of α-bromostyrene by monomeric arylpalladates Pd(Aryl)I2[NBu4] that arise upon dissociation of [Pd(Aryl)(μ-I)I]2[NBu4]2.
- 11 March 2025
- Published by Springer Nature in Nature Chemistry
- Vol. 17 (5) , 710-718
Aryl halide cross-coupling via formate-mediated transfer hydrogenation
Transfer hydrogenation is widely practised across all segments of chemical industry, yet its application to aryl halide reductive cross-coupling is undeveloped because of competing hydrogenolysis. Here, exploiting the distinct reactivity of PdI species, an efficient catalytic system for the reductive cross-coupling of activated aryl bromides with aryl iodides via formate-mediated hydrogen transfer is described. These processes display orthogonality with respect to Suzuki and Buchwald–Hartwig couplings, as pinacol boronates and anilines are tolerated and, owing to the intervention of chelated intermediates, are effective for challenging 2-pyridyl systems. Experimental and computational studies corroborate a unique catalytic cycle for reductive cross-coupling where the PdI precatalyst, [Pd(I)(PtBu3)]2, is converted to the dianionic species, [Pd2I4][NBu4]2, from which aryl halide oxidative addition is more facile. Rapid, reversible Pd-to-Pd transmetallation delivers mixtures of iodide-bridged homo- and hetero-diarylpalladium dimers. The hetero-diarylpalladium dimers are more stable and have lower barriers to reductive elimination, promoting high levels of cross-selectivity.
- 11 March 2025
- Published by Springer Nature in Nature Chemistry
- Vol. 17 (5) , 710-718
Aryl halide cross-coupling via formate-mediated transfer hydrogenation
Transfer hydrogenation is widely practised across all segments of chemical industry, yet its application to aryl halide reductive cross-coupling is undeveloped because of competing hydrogenolysis. Here, exploiting the distinct reactivity of PdI species, an efficient catalytic system for the reductive cross-coupling of activated aryl bromides with aryl iodides via formate-mediated hydrogen transfer is described. These processes display orthogonality with respect to Suzuki and Buchwald–Hartwig couplings, as pinacol boronates and anilines are tolerated and, owing to the intervention of chelated intermediates, are effective for challenging 2-pyridyl systems. Experimental and computational studies corroborate a unique catalytic cycle for reductive cross-coupling where the PdI precatalyst, [Pd(I)(PtBu3)]2, is converted to the dianionic species, [Pd2I4][NBu4]2, from which aryl halide oxidative addition is more facile. Rapid, reversible Pd-to-Pd transmetallation delivers mixtures of iodide-bridged homo- and hetero-diarylpalladium dimers. The hetero-diarylpalladium dimers are more stable and have lower barriers to reductive elimination, promoting high levels of cross-selectivity.
- 22 July 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (8) , 3313-3325
Fit-for-Purpose Synthesis of a KRASG12C Covalent Inhibitor, via a Diastereoselective Hayashi Arylation
- 22 July 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (8) , 3313-3325
Fit-for-Purpose Synthesis of a KRASG12C Covalent Inhibitor, via a Diastereoselective Hayashi Arylation
- 27 June 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (7) , 2862-2874
Streamlined Synthesis of SHP2 Inhibitor GDC-1971 Enhanced by a Telescoped Schotten-Baumann SNAr and Reactive Crystallization Cascade
- 27 June 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (7) , 2862-2874
Streamlined Synthesis of SHP2 Inhibitor GDC-1971 Enhanced by a Telescoped Schotten-Baumann SNAr and Reactive Crystallization Cascade
- Open Access
- 20 May 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Formate-Mediated Aryl Halide Reductive Cross-CouplingCatalyzed by Iodide-Bridged Palladium(I) Dimers: Experi-mental and Computational Studies
The first efficient reductive cross-couplings of aryl halides mediated by an abundant feedstock, sodium formate, are de-scribed. These processes, which exploit air-stable Pd(I) iodide dimers, are especially effective for challenging 2-pyridyl systems due to intervention of chelated intermediates. Furthermore, orthogonality with respect to Suzuki and Buchwald-Hartwig coupling processes is displayed, as pinacol boronates and anilines are tolerated. Although palladium-catalyzed transfer hydrogenolyses of aryl halides mediated by formate are longstanding, it is not a major competing pathway under the present conditions. Experimental and computational studies corroborate a novel catalytic cycle for cross-coupling where the Pd(I) precatalyst, [Pd(I)(PtBu3)]2, is converted to the active dianionic catalyst, [Pd2I4][NBu4]2, from which aryl halide oxi-dative addition is more facile. Rapid, reversible Pd-to-Pd transmetalation delivers iodide-bridged diarylpalladium dimers. The hetero-diarylpalladium dimers are more stable than the homodimers and have lower barriers to reductive elimination, resulting in high cross-selectivity.
- 20 May 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessFormate-Mediated Aryl Halide Reductive Cross-CouplingCatalyzed by Iodide-Bridged Palladium(I) Dimers: Experi-mental and Computational Studies
The first efficient reductive cross-couplings of aryl halides mediated by an abundant feedstock, sodium formate, are de-scribed. These processes, which exploit air-stable Pd(I) iodide dimers, are especially effective for challenging 2-pyridyl systems due to intervention of chelated intermediates. Furthermore, orthogonality with respect to Suzuki and Buchwald-Hartwig coupling processes is displayed, as pinacol boronates and anilines are tolerated. Although palladium-catalyzed transfer hydrogenolyses of aryl halides mediated by formate are longstanding, it is not a major competing pathway under the present conditions. Experimental and computational studies corroborate a novel catalytic cycle for cross-coupling where the Pd(I) precatalyst, [Pd(I)(PtBu3)]2, is converted to the active dianionic catalyst, [Pd2I4][NBu4]2, from which aryl halide oxi-dative addition is more facile. Rapid, reversible Pd-to-Pd transmetalation delivers iodide-bridged diarylpalladium dimers. The hetero-diarylpalladium dimers are more stable than the homodimers and have lower barriers to reductive elimination, resulting in high cross-selectivity.
- 10 May 2023
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 25 (19) , 3417-3422
Second-Generation Atroposelective Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
A chromatography-free asymmetric synthesis of GDC-6036 (1) was achieved via a highly atroposelective Negishi coupling of aminopyridine 5 and quinazoline 6b catalyzed by 0.5 mol % [Pd(cin)Cl]2 and 1 mol % (R,R)-Chiraphite to afford the key intermediate (Ra)-3. An alkoxylation of (Ra)-3 with (S)-N-methylprolinol (4) and a global deprotection generates the penultimate heterobiaryl intermediate 2. A controlled acrylamide installation by stepwise acylation/sulfone elimination and final adipate salt formation and crystallization delivered high-purity GDC-6036 (1).
- 10 May 2023
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 25 (19) , 3417-3422
Second-Generation Atroposelective Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
A chromatography-free asymmetric synthesis of GDC-6036 (1) was achieved via a highly atroposelective Negishi coupling of aminopyridine 5 and quinazoline 6b catalyzed by 0.5 mol % [Pd(cin)Cl]2 and 1 mol % (R,R)-Chiraphite to afford the key intermediate (Ra)-3. An alkoxylation of (Ra)-3 with (S)-N-methylprolinol (4) and a global deprotection generates the penultimate heterobiaryl intermediate 2. A controlled acrylamide installation by stepwise acylation/sulfone elimination and final adipate salt formation and crystallization delivered high-purity GDC-6036 (1).
- 3 November 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (45) , 20955-20963
Atroposelective Negishi Coupling Optimization Guided by Multivariate Linear Regression Analysis: Asymmetric Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
An efficient asymmetric synthesis of a potent KRAS G12C covalent inhibitor, GDC-6036 (1), is reported. The synthesis features a highly atroposelective Negishi coupling to construct the key C-C bond between two highly functionalized pyridine and quinazoline moieties by employing a Pd/Walphos catalytic system. Statistical modeling by comparing computational descriptors of a range of Walphos chiral bisphosphine ligands to a training set of experimental results was used to inform the selection of the best ligand, W057-2, which afforded the desired Negishi coupling product (Ra)-3 in excellent selectivity. A subsequent telescoped reaction sequence of alkoxylation, global deprotection, and acrylamide formation, followed by a final adipate salt formation, furnished GDC-6036 (1) in 40% overall yield from starting materials pyridine 5 and quinazoline 6.
- 3 November 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (45) , 20955-20963
Atroposelective Negishi Coupling Optimization Guided by Multivariate Linear Regression Analysis: Asymmetric Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
An efficient asymmetric synthesis of a potent KRAS G12C covalent inhibitor, GDC-6036 (1), is reported. The synthesis features a highly atroposelective Negishi coupling to construct the key C-C bond between two highly functionalized pyridine and quinazoline moieties by employing a Pd/Walphos catalytic system. Statistical modeling by comparing computational descriptors of a range of Walphos chiral bisphosphine ligands to a training set of experimental results was used to inform the selection of the best ligand, W057-2, which afforded the desired Negishi coupling product (Ra)-3 in excellent selectivity. A subsequent telescoped reaction sequence of alkoxylation, global deprotection, and acrylamide formation, followed by a final adipate salt formation, furnished GDC-6036 (1) in 40% overall yield from starting materials pyridine 5 and quinazoline 6.
- Open Access
Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
Therapeutic efficacy in COVID-19 is dependent upon disease stage and severity (treatment effect heterogeneity). Unfortunately, definitions of severity vary widely. This compromises the meta-analysis of randomised controlled trials (RCTs) and the therapeutic guidelines derived from them. The World Health Organisation ‘living’ guidelines for the treatment of COVID-19 are based on a network meta-analysis (NMA) of published RCTs. We reviewed the 81 studies included in the WHO COVID-19 living NMA and compared their severity classifications with the severity classifications employed by the international COVID-NMA initiative. The two were concordant in only 35% (24/68) of trials. Of the RCTs evaluated 69% (55/77) were considered by the WHO group to include patients with a range of severities (12 mild-moderate; 3 mild-severe; 18 mild-critical; 5 moderate-severe; 8 moderate-critical; 10 severe-critical), but the distribution of disease severities within these groups usually could not be determined, and data on the duration of illness and/or oxygen saturation values were often missing. Where severity classifications were clear there was substantial overlap in mortality across trials in different severity strata. This imprecision in severity assessment compromises the validity of some therapeutic recommendations; notably extrapolation of “lack of therapeutic benefit” shown in hospitalised severely ill patients on respiratory support to ambulant mildly ill patients is not warranted. Both harmonised unambiguous definitions of severity and individual patient data meta-analyses are needed to guide and improve therapeutic recommendations in COVID-19.
Open AccessDefinitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
Therapeutic efficacy in COVID-19 is dependent upon disease stage and severity (treatment effect heterogeneity). Unfortunately, definitions of severity vary widely. This compromises the meta-analysis of randomised controlled trials (RCTs) and the therapeutic guidelines derived from them. The World Health Organisation ‘living’ guidelines for the treatment of COVID-19 are based on a network meta-analysis (NMA) of published RCTs. We reviewed the 81 studies included in the WHO COVID-19 living NMA and compared their severity classifications with the severity classifications employed by the international COVID-NMA initiative. The two were concordant in only 35% (24/68) of trials. Of the RCTs evaluated 69% (55/77) were considered by the WHO group to include patients with a range of severities (12 mild-moderate; 3 mild-severe; 18 mild-critical; 5 moderate-severe; 8 moderate-critical; 10 severe-critical), but the distribution of disease severities within these groups usually could not be determined, and data on the duration of illness and/or oxygen saturation values were often missing. Where severity classifications were clear there was substantial overlap in mortality across trials in different severity strata. This imprecision in severity assessment compromises the validity of some therapeutic recommendations; notably extrapolation of “lack of therapeutic benefit” shown in hospitalised severely ill patients on respiratory support to ambulant mildly ill patients is not warranted. Both harmonised unambiguous definitions of severity and individual patient data meta-analyses are needed to guide and improve therapeutic recommendations in COVID-19.